These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19805545)

  • 1. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.
    Hong SK; Yoon S; Moelling C; Arthan D; Park JI
    J Biol Chem; 2009 Nov; 284(48):33006-18. PubMed ID: 19805545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active ERK2 is sufficient to mediate growth arrest and differentiation signaling.
    Wu PK; Hong SK; Yoon SH; Park JI
    FEBS J; 2015 Mar; 282(6):1017-30. PubMed ID: 25639353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.
    Hong SK; Wu PK; Park JI
    Cell Signal; 2018 Jan; 42():11-20. PubMed ID: 28986121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.
    Hong SK; Kim JH; Lin MF; Park JI
    Exp Cell Res; 2011 Nov; 317(18):2671-82. PubMed ID: 21871886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
    Eblen ST; Catling AD; Assanah MC; Weber MJ
    Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2.
    Frémin C; Bessard A; Ezan F; Gailhouste L; Régeard M; Le Seyec J; Gilot D; Pagès G; Pouysségur J; Langouët S; Baffet G
    Hepatology; 2009 Mar; 49(3):930-9. PubMed ID: 19177593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
    Wei F; Xie Y; Tao L; Tang D
    Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total ERK1/2 activity regulates cell proliferation.
    Lefloch R; Pouysségur J; Lenormand P
    Cell Cycle; 2009 Mar; 8(5):705-11. PubMed ID: 19242111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is.
    Yen A; Varvayanis S
    In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):249-55. PubMed ID: 10852350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing.
    Bae D; Ceryak S
    Biochem Biophys Res Commun; 2009 Aug; 385(4):523-7. PubMed ID: 19465001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained extracellular signal-regulated kinase1/2 mitogen-activated protein kinase signalling is related to increased p21 expression in cholesteatoma epithelium.
    Huisman MA; De Heer E; Grote JJ
    Acta Otolaryngol; 2005 Feb; 125(2):134-40. PubMed ID: 15880942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation.
    Crowe MS; Zavorotinskaya T; Voliva CF; Shirley MD; Wang Y; Ruddy DA; Rakiec DP; Engelman JA; Stuart DD; Freeman AK
    Mol Cancer Res; 2021 Jun; 19(6):1063-1075. PubMed ID: 33707308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.
    Vantaggiato C; Formentini I; Bondanza A; Bonini C; Naldini L; Brambilla R
    J Biol; 2006; 5(5):14. PubMed ID: 16805921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation.
    Voisin L; Saba-El-Leil MK; Julien C; Frémin C; Meloche S
    Mol Cell Biol; 2010 Jun; 30(12):2918-32. PubMed ID: 20368360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
    Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
    Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells.
    Robertson BW; Bonsal L; Chellaiah MA
    Mol Cancer; 2010 Sep; 9():260. PubMed ID: 20868520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.